Hong Liu

Hong Liu

Auto-generated profile, based on publicly available information

Hong Liu

Department of Cardiovascular Surgery, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2022 in Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Verified
Journal Article
Open access
HLHong Liu
Hong Liu
SQSi-Chong Qian
Si-Chong Qian
YZYing-Yuan Zhang
Ying-Yuan Zhang
YWYing Wu
Ying Wu
LHLiang Hong
Liang Hong
HZHong-Jia Zhang
Hong-Jia Zhang
To develop an inflammation-based risk stratification tool for operative mortality in patients with acute type A aortic dissection. Between January 1, 2016 and December 31, 2021, 3124 patients from Beijing Anzhen Hospital were included for derivation, 571 patients from the same hospital were included for internal validation, and 1319 patients from other 12 hospitals were included for external validation. The primary outcome was operative mortality according to the Society of Thoracic Surgeons criteria. Least absolute shrinkage and selection operator regression were used to identify clinical risk factors. A model was developed using different machine learning algorithms. The performance of the model was determined using the area under the receiver operating characteristic curve (AUC) for discrimination, calibration curves, and Brier score for calibration. The final model (5A score) was tested with respect to the existing clinical scores. Extreme gradient boosting was selected for model training (5A score) using 12 variables for prediction—the ratio of platelet to leukocyte count, creatinine level, age, hemoglobin level, prior cardiac surgery, extent of dissection extension, cerebral perfusion, aortic regurgitation, sex, pericardial effusion, shock, and coronary perfusion—which yields the highest AUC (0.873 [95% confidence interval (CI) 0.845-0.901]). The AUC of 5A score was 0.875 (95% CI 0.814-0.936), 0.845 (95% CI 0.811-0.878), and 0.852 (95% CI 0.821-0.883) in the internal, external, and total cohort, respectively, which outperformed the best existing risk score (German Registry for Acute Type A Aortic Dissection score AUC 0.709 [95% CI 0.669-0.749]). The 5A score is a novel, internally and externally validated inflammation-based tool for risk stratification of patients before surgical repair, potentially advancing individualized treatment. clinicaltrials.gov Identifier: NCT04918108

4 October 2022 in JACC: Asia
Verified
Journal Article
Open access
HLHong Liu
Hong Liu
SQSi-Chong Qian
Si-Chong Qian
YSYongfeng Shao
Yongfeng Shao
HLHaiyang Li
Haiyang Li
HZHong-Jia Zhang
Hong-Jia Zhang
A novel hematologic parameter, systemic coagulation-inflammation (SCI) index reflecting inflammation and coagulation pathways could be easily obtained from clinically routine laboratory findings. We hypothesize that the SCI index has prognostic implication in predicting operative mortality for patients with acute type A aortic dissection (ATAAD). This study aims to investigate the prognostic value of the SCI index and to establish an SCI-adding nomogram for mortality prediction in ATAAD patients. A total of 1,967 ATAAD patients surgically repaired were collected from 12 Chinese cardiovascular centers by the 5A (Additive Anti-inflammatory Action for Aortopathy & Arteriopathy [Multicenter Retrospective Study]) study III (2016-2020). SCI index was calculated as platelet count × fibrinogen/white blood cell count on admission. By adding SCI index, a nomogram was developed and evaluated for 90-day mortality prediction with conventional predictors via the Cox model with 10-fold cross-validation. Patients were stratified with low SCI (100). The 90-day survival rates increased with SCI index (low 86.9%; [95% CI: 84.9%-89.0%], middle 92.7% [95% CI: 90.9%-94.9%], and high 96.4% [95% CI: 94.2%-98.6%]; log-rank P < 0.001). SCI index is independently associated with 90-day mortality (adjusted hazard ratio: 0.549; 95% CI: 0.424-0.710; P < 0.001). The addition of SCI index provided significantly incremental prognostic value to base model including age, serum creatinine, DeBakey class, and location of intimal entry (area under the curve: 0.677; 95% CI: 0.641-0.716 vs 0.724; 95% CI: 0.685-0.760; P = 0.002), which was confirmed by net reclassification improvement index (0.158; 95% CI: 0.065-0.235; P < 0.001) and integrated discrimination improvement index (0.070; 95% CI: 0.007-0.036; P < 0.001). SCI index is easily obtainable, performs moderately well as a predictor of short-term mortality in ATAAD patients, and may be useful for risk stratification in emergency settings. (Additive Anti-inflammatory Action for Aortopathy & Arteriopathy [Multicenter Retrospective Study] III NCT04918108)

5 November 2019 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
HLHong Liu
Hong Liu
SZSi‐Qiang Zheng
Si‐Qiang Zheng
XLXin‐Ya Li
Xin‐Ya Li
ZZZhi‐Hua Zeng
Zhi‐Hua Zeng
JZJi‐Sheng Zhong
Ji‐Sheng Zhong
YSYongfeng Shao
Yongfeng Shao
Background: We aimed to develop and validate a prediction model for in‐hospital complications in children with tetralogy of Fallot repaired at an older age. Methods and Results: A total of 513 pediatric patients from the Tianjin data set formed a derivation cohort, and 158 pediatric patients from the Hefei and Xiamen data sets formed validation cohorts. We applied least absolute shrinkage and selection operator analysis for variable selection and logistic regression coefficients for risk scoring. We classified patients into different risk categorizations by threshold analysis and investigated the association with in‐hospital complications using logistic regression. In‐hospital complications were defined as death, need for extensive pharmacologic support (vasoactive‐inotrope score of ≥20), and need for mechanical circulatory support. We developed a nomogram based on risk classifier and independent baseline variables using a multivariable logistic model. Based on risk scores weighted by 11 preoperative and 4 intraoperative selected variables, we classified patients as low, intermediate, and high risk in the derivation cohort. With reference to the low‐risk group, the intermediate‐ and high‐risk groups conferred significantly higher in‐hospital complication risks (adjusted odds ratio: 2.721 [95% CI, 1.267–5.841], P =0.0102; 9.297 [95% CI, 4.601–18.786], P <0.0001). A nomogram integrating the ARIAR ‐Risk classifier (absolute and relative low risk, intermediate risk, and aggressive and refractory high risk) with age and mean blood pressure showed good discrimination and goodness‐of‐fit for derivation (area under the receiver operating characteristic curve: 0.785 [95% CI , 0.731–0.839]; Hosmer‐Lemeshow test, P =0.544) and external validation (area under the receiver operating characteristic curve: 0.759 [95% CI , 0.636–0.881]; Hosmer‐Lemeshow test, P =0.508). Conclusions: A risk‐classifier–oriented nomogram is a reliable prediction model for in‐hospital complications in children with tetralogy of Fallot repaired at an older age, and strengthens risk/benefit–based decision‐making.

15 September 2023 in Journal of Cardiovascular Translational Research
Verified
Journal Article
Closed access
PDF file
HZHong-Lei Zhao
Hong-Lei Zhao
ZTZhi-Wei Tang
Zhi-Wei Tang
YDYi-Fei Diao
Yi-Fei Diao
XXXiu-Fan Xu
Xiu-Fan Xu
SQSi-Chong Qian
Si-Chong Qian
HLHong Liu
Hong Liu

25 April 2023 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
HLHong Liu
Hong Liu
YZYing-Yuan Zhang
Ying-Yuan Zhang
XDXiao-Hang Ding
Xiao-Hang Ding
SQSi-Chong Qian
Si-Chong Qian
MSMing-Yu Sun
Ming-Yu Sun
HZHong-Jia Zhang
Hong-Jia Zhang

1 November 2022 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
PDF file
HLHong Liu
Hong Liu
SQSi-Chong Qian
Si-Chong Qian
LHLu Han
Lu Han
YZYing-Yuan Zhang
Ying-Yuan Zhang
YWYing Wu
Ying Wu
HZHong-Jia Zhang
Hong-Jia Zhang
Aims: The incremental usefulness of circulating biomarkers from different pathological pathways for predicting mortality has not been evaluated in acute Type A aortic dissection (ATAAD) patients. We aim to develop a risk prediction model and investigate the impact of arch repair strategy on mortality based on distinct risk stratifications.Methods and results: A total of 3771 ATAAD patients who underwent aortic surgery retrospectively included were randomly divided into training and testing cohorts at a ratio of 7:3 for the development and validation of the risk model based on multiple circulating biomarkers and conventional clinical factors. Extreme gradient boosting was used to generate the risk models. Subgroup analyses were performed by risk stratifications (low vs. middle–high risk) and arch repair strategies (proximal vs. extensive arch repair). Addition of multiple biomarkers to a model with conventional factors fitted an ABC risk model consisting of platelet–leucocyte ratio, mean arterial pressure, albumin, age, creatinine, creatine kinase-MB, haemoglobin, lactate, left ventricular end-diastolic dimension, urea nitrogen, and aspartate aminotransferase, with adequate discrimination ability {area under the receiver operating characteristic curve (AUROC): 0.930 [95% confidence interval (CI) 0.906–0.954] and 0.954, 95% CI (0.930–0.977) in the derivation and validation cohort, respectively}. Compared with proximal arch repair, the extensive repair was associated with similar mortality risk among patients at low risk [odds ratio (OR) 1.838, 95% CI (0.559–6.038); P = 0.316], but associated with higher mortality risk among patients at middle–high risk [OR 2.007, 95% CI (1.460–2.757); P < 0.0001].Conclusion: In ATAAD patients, the simultaneous addition of circulating biomarkers of inflammatory, cardiac, hepatic, renal, and metabolic abnormalities substantially improved risk stratification and individualized arch repair strategy.